ALEXANDER SCHIRGER, M.D.; WILLIAM J. MARTIN, M.D.; DONALD R. NICHOLS, M.D., F.A.C.P.
Infections caused by Micrococcus pyogenes var. aureus (Staphylococcus pyogenes aureus)continue to offer a major therapeutic challenge. Micrococci appear to possess an almost singular ability to demonstrate progressive resistance to new antibacterial agents. Experiences of our group at the Mayo Clinic with bacteremia without endocarditis produced by gram-negative and some gram-positive organisms have been described recently.1, 3 The present study reviews our experiences in patients who had bacteremia without endocarditis caused by M. pyogenes. Data relating to patients with micrococcal endocarditis will be presented at a later date. Collins and associates4 recently commented on the near absence in current medical literature
SCHIRGER A, MARTIN WJ, NICHOLS DR. MICROCOCCAL BACTEREMIA WITHOUT ENDOCARDITIS: CLINICAL DATA AND THERAPEUTIC CONSIDERATIONS IN 109 CASES1. Ann Intern Med. ;47:39–48. doi: 10.7326/0003-4819-47-1-39
Download citation file:
Published: Ann Intern Med. 1957;47(1):39-48.
Cardiology, Endocarditis, Infectious Disease, Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use